17 results
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company NV
8 May 24
Quarterly report
4:30pm
global health crises could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified … , regulatory and policy changes, the FDA’s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed … , the FDA’s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA’s ability
424B3
NAMS
NewAmsterdam Pharma Company NV
15 Aug 23
Prospectus supplement
4:52pm
at the FDA and other regulatory agencies caused by funding shortages or future global health crises could hinder their ability to hire, retain … by a variety of factors, including government budget and funding levels, statutory, regulatory and policy changes, the FDA’s ability to hire and retain key
POS AM
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
agencies caused by funding shortages or future global health crises could hinder their ability to hire, retain or deploy key leadership and other … government budget and funding levels, statutory, regulatory and policy changes, the FDA’s ability to hire and retain key personnel and accept the payment
6-K
EX-99.2
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Research and development expenses
7:24am
regulatory agencies caused by funding shortages or future global health crises could hinder their ability to hire, retain or deploy key leadership … , including government budget and funding levels, statutory, regulatory and policy changes, the FDA’s ability to hire and retain key personnel and accept
424B3
vk4gf4h5wo31ualh
8 Jun 23
Prospectus supplement
5:01pm
424B3
1s1c7fz o8zznh
6 Jun 23
Prospectus supplement
4:20pm
424B3
rzrbkzth
25 Apr 23
Prospectus supplement
8:14am
POS AM
eeatr0p2yjs16dqr
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
ggdjgi djhpcvx
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-2.1
3zp nieuxx
23 Nov 22
Current report (foreign)
4:36pm
424B3
3i8lj tsll3m
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
frw3llvmc4hskure13h
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
28c6r9
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
wzyqg4rdsxay7ofb
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
18tl80g
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next